Tribute Pharmaceuticals Canada (SLRXF) 8-K/A Changes in Registrant.s Certifying Accountant

Exhibit 99.1

March 6, 2008

United States Securities and Exchange Commission

Judiciary Plaza

450 Fifth Street N.W.

Washington, D.C. 20549

U.S.A.

To Whom It May Concern:

Re: Stellar Pharmaceuticals Inc.

This is to confirm that Mintz & Partners, LLP (having merged effective January 29, 2008 with Deloitte & Touche LLP) confirms that it agrees with  the disclosure contained in the report of Stellar Pharmaceuticals Inc. filed on Form 8-k entitled  “Changes in Registrant’s Certifying Accountant”.

Yours very truly,

/s/ MINTZ & PARTNERS LLP

A Pre-decessor firm to Deloitte & Touche LLP

Per: Allan Cheskes, C.A.

Partner

Direct Line:

416-644-4381

Direct Fax:

416-644-4382

E-Mail:

allan_cheskes@mintzca.com